Form 4: Century Therapeutics SVP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Douglas Carr, SVP Finance & Operations at Century Therapeutics, sold 351 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Douglas Carr, SVP Finance & Operations at Century Therapeutics, sold 351 shares of common stock on February 3, 2025.
- The sale was executed at a price of $0.78 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Carr directly owns 316,796 shares of Century Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This sale appears to be routine, covering tax obligations related to vested equity.
Key Dates
| Date | Description |
|---|---|
| 02/03/2025 | Date of the stock sale transaction. |
| 02/05/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Century Therapeutics, Insider Trading, Stock Sale, Douglas Carr, IPSC, Tax Withholding, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.